Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Finetti

Showing results (61-70 of 180) with videos related to

Pageof 18
Sort By:
British Journal of Cancer|October 25, 2018
The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancerFrançois Bertucci, Pascal Finetti, Ines Simeone, et al.
Oncoimmunology|April 14, 2017
PDL1 expression is a poor-prognosis factor in soft-tissue sarcomasFrançois Bertucci, Pascal Finetti, Delphine Perrot, et al.
Cancers|July 2, 2021
Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to ChemotherapyGayathri R Devi, Pascal Finetti, Michael A Morse, et al.
Pharmaceutics|July 29, 2023
<i>ZNF703</i> mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell LinesSandra Udu-Ituma, José Adélaïde, Thi Khanh Le, et al.
Plos One|June 6, 2012
8q24 Cancer risk allele associated with major metastatic risk in inflammatory breast cancerFrançois Bertucci, Arnaud Lagarde, Anthony Ferrari, et al.
Molecular & Cellular Proteomics : MCP|October 4, 2014
The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targetsMaria Katsogiannou, Claudia Andrieu, Virginie Baylot, et al.
BMC Medicine|September 21, 2017
A 25-gene classifier predicts overall survival in resectable pancreatic cancerDavid J Birnbaum, Pascal Finetti, Alexia Lopresti, et al.
Cancers|January 21, 2023
PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular CarcinomaDavid Jeremie Birnbaum, Maelle Picard, Quentin Da Costa, et al.
Plos One|March 9, 2010
Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse modelMartine Humbert, Nathalie Castéran, Sébastien Letard, et al.
Cancer Research|March 23, 2005
Gene expression profiling identifies molecular subtypes of inflammatory breast cancerFrançois Bertucci, Pascal Finetti, Jacques Rougemont, et al.
Pageof 18

Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
British Journal of Cancer|October 25, 2018
The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancerFrançois Bertucci, Pascal Finetti, Ines Simeone, et al.
Oncoimmunology|April 14, 2017
PDL1 expression is a poor-prognosis factor in soft-tissue sarcomasFrançois Bertucci, Pascal Finetti, Delphine Perrot, et al.
Cancers|July 2, 2021
Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to ChemotherapyGayathri R Devi, Pascal Finetti, Michael A Morse, et al.
Pharmaceutics|July 29, 2023
<i>ZNF703</i> mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell LinesSandra Udu-Ituma, José Adélaïde, Thi Khanh Le, et al.
Plos One|June 6, 2012
8q24 Cancer risk allele associated with major metastatic risk in inflammatory breast cancerFrançois Bertucci, Arnaud Lagarde, Anthony Ferrari, et al.
Molecular & Cellular Proteomics : MCP|October 4, 2014
The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targetsMaria Katsogiannou, Claudia Andrieu, Virginie Baylot, et al.
BMC Medicine|September 21, 2017
A 25-gene classifier predicts overall survival in resectable pancreatic cancerDavid J Birnbaum, Pascal Finetti, Alexia Lopresti, et al.
Cancers|January 21, 2023
PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular CarcinomaDavid Jeremie Birnbaum, Maelle Picard, Quentin Da Costa, et al.
Plos One|March 9, 2010
Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse modelMartine Humbert, Nathalie Castéran, Sébastien Letard, et al.
Cancer Research|March 23, 2005
Gene expression profiling identifies molecular subtypes of inflammatory breast cancerFrançois Bertucci, Pascal Finetti, Jacques Rougemont, et al.
Pageof 18